2 ms·
Of which there are surprisingly few. Big pharma has trouble marketing those, typical attempts include Alzheimer, stroke management, ADD and narcolepsy, which ar
by AstralStorm 10y ago
Of which there are surprisingly few. Big pharma has trouble marketing those, typical attempts include Alzheimer, stroke management, ADD and narcolepsy, which are pretty hard to run a trial for. These are good enough to establish safety at least.
There are even fewer in people without disorders.